The Birmingham Hip Resurfacing (BHR) procedure was first introduced in 1997 in the UK by Derek McMinn and Ronan Tracy, and it was the first FDA-authorized hip resurfacing procedure available for US citizens, receiving approval in May 2006.
BHR is a less invasive option compared to Total Hip Replacement and it was designed to preserve more native bone in the femur's head and neck. With more bone available younger patients will have more options for future interventions if they're required, including a conventional hip replacement.
Birmingham Hip Resurfacing begins by administering a general or spinal anesthetic to sedate the patient during the procedure. The surgical intervention can last between 1 ½ and 3 hours, usually averaging 2 hours.
After the anesthetic wears off, the patient will usually spend 1 or 2 days in admission or longer, depending on the degree of the injury and other conditions. An X-ray may be required to ensure that the intervention was successful.
Patients will likely experience some degree of pain and require mobility aids to alleviate the pressure on the reconstructed hip. Painkillers like nonsteroidal anti-inflammation drugs are usually prescribed to ease post-operative pain. Physical therapy will begin soon to help regain mobility and strength.
Rehabilitation from BHR surgery usually involves three stages:
Generally, patients can expect to resume regular activities 6 weeks after their intervention. Patients can expect a full return to unrestricted activities and sports after 12 months of adequate rehabilitation.